rs6702590

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000069.3(CACNA1S):​c.4113+7T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.708 in 1,613,468 control chromosomes in the GnomAD database, including 412,372 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 47269 hom., cov: 31)
Exomes 𝑓: 0.70 ( 365103 hom. )

Consequence

CACNA1S
NM_000069.3 splice_region, intron

Scores

2
Splicing: ADA: 0.000007173
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.150

Publications

18 publications found
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]
CACNA1S Gene-Disease associations (from GenCC):
  • hypokalemic periodic paralysis, type 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • malignant hyperthermia, susceptibility to, 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • congenital myopathy 18
    Inheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myopathy
    Inheritance: SD, AD, AR Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 1-201050977-A-G is Benign according to our data. Variant chr1-201050977-A-G is described in ClinVar as Benign. ClinVar VariationId is 199680.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.971 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000069.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
NM_000069.3
MANE Select
c.4113+7T>C
splice_region intron
N/ANP_000060.2Q13698

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
ENST00000362061.4
TSL:1 MANE Select
c.4113+7T>C
splice_region intron
N/AENSP00000355192.3Q13698
CACNA1S
ENST00000367338.7
TSL:5
c.4056+7T>C
splice_region intron
N/AENSP00000356307.3B1ALM3
CACNA1S
ENST00000681874.1
c.4053+7T>C
splice_region intron
N/AENSP00000505162.1A0A7P0T8M7

Frequencies

GnomAD3 genomes
AF:
0.779
AC:
118370
AN:
152036
Hom.:
47206
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.929
Gnomad AMI
AF:
0.508
Gnomad AMR
AF:
0.802
Gnomad ASJ
AF:
0.744
Gnomad EAS
AF:
0.994
Gnomad SAS
AF:
0.876
Gnomad FIN
AF:
0.770
Gnomad MID
AF:
0.715
Gnomad NFE
AF:
0.666
Gnomad OTH
AF:
0.775
GnomAD2 exomes
AF:
0.775
AC:
194789
AN:
251432
AF XY:
0.769
show subpopulations
Gnomad AFR exome
AF:
0.937
Gnomad AMR exome
AF:
0.868
Gnomad ASJ exome
AF:
0.745
Gnomad EAS exome
AF:
0.996
Gnomad FIN exome
AF:
0.762
Gnomad NFE exome
AF:
0.669
Gnomad OTH exome
AF:
0.756
GnomAD4 exome
AF:
0.701
AC:
1024126
AN:
1461314
Hom.:
365103
Cov.:
45
AF XY:
0.705
AC XY:
512320
AN XY:
726970
show subpopulations
African (AFR)
AF:
0.941
AC:
31489
AN:
33480
American (AMR)
AF:
0.865
AC:
38677
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.743
AC:
19407
AN:
26126
East Asian (EAS)
AF:
0.983
AC:
39038
AN:
39696
South Asian (SAS)
AF:
0.867
AC:
74770
AN:
86252
European-Finnish (FIN)
AF:
0.758
AC:
40486
AN:
53420
Middle Eastern (MID)
AF:
0.773
AC:
4448
AN:
5752
European-Non Finnish (NFE)
AF:
0.658
AC:
731550
AN:
1111488
Other (OTH)
AF:
0.733
AC:
44261
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
15296
30592
45887
61183
76479
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19208
38416
57624
76832
96040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.779
AC:
118493
AN:
152154
Hom.:
47269
Cov.:
31
AF XY:
0.786
AC XY:
58431
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.929
AC:
38564
AN:
41520
American (AMR)
AF:
0.802
AC:
12273
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.744
AC:
2581
AN:
3470
East Asian (EAS)
AF:
0.994
AC:
5125
AN:
5156
South Asian (SAS)
AF:
0.875
AC:
4223
AN:
4824
European-Finnish (FIN)
AF:
0.770
AC:
8156
AN:
10596
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.666
AC:
45256
AN:
67974
Other (OTH)
AF:
0.777
AC:
1641
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1276
2553
3829
5106
6382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.719
Hom.:
17212
Bravo
AF:
0.790
Asia WGS
AF:
0.928
AC:
3226
AN:
3478
EpiCase
AF:
0.683
EpiControl
AF:
0.670

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
2
Hypokalemic periodic paralysis, type 1 (2)
-
-
2
not provided (2)
-
-
1
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.18
DANN
Benign
0.54
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000072
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6702590; hg19: chr1-201020105; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.